Fieldpoint Private Securities, LLC Vanda Pharmaceuticals Inc. Transaction History

Fieldpoint Private Securities, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 05, 2022	SELL	$9.31 - $11.84 $2,793 - $3,552	-300 Closed	0 $0
Q1 2022 Apr 07, 2022	SELL	$10.84 - $16.55 $1,734 - $2,648	-160 Reduced 34.78%	300 $3,000
Q4 2021 Jan 24, 2022	SELL	$15.69 - $21.14 $784 - $1,057	-50 Reduced 9.8%	460 $7,000
Q3 2021 Nov 12, 2021	BUY	$15.35 - $21.27 $1,381 - $1,914	90 Added 21.43%	510 $9,000
Q1 2021 Apr 23, 2021	BUY	$13.42 - $20.28 $805 - $1,216	60 Added 16.67%	420 $6,000
Q4 2020 Jan 28, 2021	BUY	$9.77 - $13.81 $3,517 - $4,971	360 New	360 $5,000

161

45.2M

165K

33.6K

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $273M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

Get notified when there are updates to the investment portfolio of Fieldpoint Private Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Fieldpoint Private Securities, LLC with notifications on news.